SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001214659-24-016381
Filing Date
2024-09-12
Accepted
2024-09-12 16:10:26
Documents
1
Group Members
KEVIN TANGTANG CAPITAL PARTNERS III, INCTANG CAPITAL PARTNERS IV, INCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 e910242sc13d.htm SC 13D 157185
  Complete submission text file 0001214659-24-016381.txt   158892
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

IRS No.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88628 | Film No.: 241295043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)